Sign Out
Animal studies have demonstrated teratogenic effects, Vinblastine Sulfate should not be administered in pregnant women or women suspected of pregnancy.
Safety use in lactation has not been established and therefore breast feeding should be avoided during the therapy.
Continue with Google